Welcome to Paid Research Studies




  • Condition:   Gynecologic Cancer
    Interventions:   Device: MRI;   Radiation: Brachytherapy;   Device: MRI Tracker
    Sponsors:   Dana-Farber Cancer Institute;   Friends of Dana-Farber, Dana-Farber Cancer Institute;   Kaye Foundation, Brigham and Women's Hospital
    Recruiting

  • Condition:   Gynecologic Cancer
    Intervention:   Behavioral: dedicated sexual health clinic appointment
    Sponsor:   Case Comprehensive Cancer Center
    Not yet recruiting

  • Conditions:   Stage III Gynecologic Cancer;   Stage IV Gynecologic Cancer
    Interventions:   Other: Mindfulness meditation;   Other: Usual care packet
    Sponsors:   Washington University School of Medicine;   Washington University Department of Psychological and Brain Sciences
    Recruiting

  • Condition:   Gynecologic Cancer
    Interventions:   Device: Fitbit Zip;   Other: HOPE App;   Other: Standard of Care;   Device: Fitbit Charge 2
    Sponsor:   Dana-Farber Cancer Institute
    Recruiting

  • Condition:   Gynecologic Cancer
    Intervention:   Drug: PSMA-based 18F-DCFPyL PET tracer
    Sponsor:   University of Wisconsin, Madison
    Recruiting

  • Conditions:   Chemotherapy-induced Peripheral Neuropathy;   Breast Cancer Female;   Gynecologic Cancer
    Intervention:   Device: Acupuncture
    Sponsor:   University of Utah
    Not yet recruiting

  • Conditions:   Gynecologic Cancer;   Cervical Cancer
    Intervention:  
    Sponsor:   Dana-Farber Cancer Institute
    Recruiting

  • Conditions:   Recurrent Cervical Carcinoma;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Vaginal Carcinoma;   Stage IV Cervical Cancer AJCC v8;   Stage IV Fallopian Tube Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Primary Peritoneal Cancer AJCC v8;   Stage IV Uterine Corpus Cancer AJCC v8;   Stage IV Vaginal Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Fallopian Tube Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Primary Peritoneal Cancer AJCC v8;   Stage IVA Uterine Corpus Cancer AJCC v8;   Stage IVA Vaginal Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Fallopian Tube Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Primary Peritoneal Cancer AJCC v8;   Stage IVB Uterine Corpus Cancer AJCC v8;   Stage IVB Vaginal Cancer AJCC v8
    Interventions:   Procedure: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Talazoparib
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer;   Uterine Endometrial Cancer
    Intervention:  
    Sponsors:   Duke University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Malignant Peritoneal Neoplasm;   Malignant Retroperitoneal Neoplasm;   Peritoneal Carcinomatosis;   Platinum-Resistant Fallopian Tube Carcinoma;   Platinum-Resistant Ovarian Carcinoma;   Platinum-Resistant Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Stage IV Cervical Cancer AJCC v8;   Stage IV Fallopian Tube Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Primary Peritoneal Cancer AJCC v8;   Stage IVA Cervical Cancer AJCC v8;   Stage IVA Fallopian Tube Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Primary Peritoneal Cancer AJCC v8;   Stage IVB Cervical Cancer AJCC v8;   Stage IVB Fallopian Tube Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Primary Peritoneal Cancer AJCC v8
    Interventions:   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Other: Pharmacokinetic Study
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Recurrent Gynecological Cancer;   Metastatic Cervical Cancer;   Metastatic Ovarian Cancer;   Metastatic Vaginal Cancer;   Metastatic Vulvar Cancer;   Metastatic Endometrial Cancer;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Recurrent Endometrial Cancer
    Interventions:   Drug: Durvalumab;   Drug: Tremelimumab;   Radiation: Radiation Therapy
    Sponsors:   Dana-Farber Cancer Institute;   AstraZeneca
    Recruiting

  • Conditions:   Gynecologic Cancer;   Sexual Dysfunction
    Interventions:   Drug: Lidocaine Topical;   Drug: Placebo
    Sponsor:   David Bender
    Not yet recruiting

  • Conditions:   Gynecologic Cancer;   Venous Thromboembolism
    Interventions:   Drug: Oral apixaban;   Drug: Subcutaneous enoxaparin
    Sponsors:   University of Colorado, Denver;   Bristol-Myers Squibb
    Recruiting

  • Conditions:   Advanced Solid Tumor;   Gynecologic Cancer
    Interventions:   Drug: Lucitanib;   Drug: Nivolumab
    Sponsors:   Clovis Oncology, Inc.;   Bristol-Myers Squibb
    Recruiting

  • Conditions:   Advanced Lung Carcinoma;   Malignant Female Reproductive System Neoplasm;   Stage III Lung Cancer AJCC v8;   Stage IIIA Lung Cancer AJCC v8;   Stage IIIB Lung Cancer AJCC v8;   Stage IIIC Lung Cancer AJCC v8;   Stage IV Lung Cancer AJCC v8
    Interventions:   Behavioral: Psychosocial Care Conquer Fear Support intervention (psychoeducation, attention training, worry management, and detached mindfulness components);   Other: Questionnaire Administration
    Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Caregiver;   Malignant Female Reproductive System Neoplasm
    Interventions:   Other: Questionnaire Administration;   Other: Video
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Breast Cancer;   Peripheral Neuropathy;   Gynecologic Cancer
    Interventions:   Other: Yoga;   Other: Wait List Control
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Conditions:   Cervical Adenosarcoma;   Cervical Adenosquamous Carcinoma;   Cervical Carcinosarcoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Endometrioid Adenocarcinoma;   Endometrial Mixed Adenocarcinoma;   Endometrial Mucinous Adenocarcinoma;   Endometrial Squamous Cell Carcinoma;   Endometrial Transitional Cell Carcinoma;   Endometrial Undifferentiated Carcinoma;   Fallopian Tube Adenocarcinoma;   Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Malignant Ovarian Epithelial Tumor;   Malignant Peritoneal Neoplasm;   Ovarian Carcinosarcoma;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Melanoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Stage IV Skin Melanoma;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma;   Uterine Corpus Carcinosarcoma
    Interventions:   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation;   Other: Pharmacological Study
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Postoperative Pain;   Postoperative Nausea and Vomiting;   Opioid Use
    Interventions:   Procedure: TAP Block;   Procedure: Surgical Site Infiltration;   Drug: Exparel
    Sponsor:   Danbury Hospital
    Recruiting

  • Conditions:   Gynecologic Cancer;   Adjustment;   Gastrointestinal Cancer;   Thoracic Cancer
    Intervention:   Behavioral: Stilling the Waters of Uncertainty: A yoga program for women with gynecologic, gastrointestinal (GI), or thoracic cancer
    Sponsor:   University of Florida
    Recruiting

  • Conditions:   Intraoperative Complication;   Malignant Female Reproductive System Neoplasm;   Pain
    Interventions:   Drug: Epidural analgesia;   Other: Intraoperative Complication Management and Prevention;   Procedure: Pain Therapy
    Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Breast Cancer;   Ovarian Cancer;   Gynecologic Cancers;   Ovarian/Peritoneal/Fallopian Cancer
    Intervention:  
    Sponsors:   Stanford University;   United States Department of Defense
    Recruiting

  • Conditions:   Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer;   Vulvar Cancer;   Gynecologic Cancer
    Intervention:   Behavioral: Questionnaires
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting

  • Conditions:   Breast Carcinoma;   Cervical Carcinoma;   Ovarian Carcinoma;   Postmenopausal;   Uterine Corpus Cancer;   Vaginal Carcinoma;   Vulvar Carcinoma
    Interventions:   Drug: Bupropion Hydrochloride;   Other: Placebo
    Sponsors:   NRG Oncology;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Endometrial Cancer;   Papillary Serous;   Clear Cell Endometrial Cancer
    Interventions:   Radiation: Vaginal Cuff Brachytherapy;   Drug: Carboplatin;   Drug: Paclitaxel
    Sponsor:   University of Oklahoma
    Recruiting

  • Conditions:   Metastatic Cancer;   Locally Advanced Cancer;   Thoracic Cancer;   Gynecologic Cancer;   Genitourinary Cancer;   Lymphoma
    Intervention:   Behavioral: Weekly 45 minute Sessions
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Weill Medical College of Cornell University
    Recruiting

  • Conditions:   Head and Neck Cancer;   Prostate Cancer;   Breast Cancer;   Lung Cancer;   Gynecologic Cancer;   Gastrointestinal Cancer
    Interventions:   Other: Survey;   Other: Saliva sample;   Other: Smoking Status questions
    Sponsors:   Medical University of South Carolina;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Non-myeloablative TCR Alpha/Beta-depleted Haploidentical Hematopoietic Stem Cell Transplantation;   Recurrent Lip and Oral Cavity Carcinoma;   Recurrent Malignant Endocrine Neoplasm;   Recurrent Malignant Female Reproductive System Neoplasm;   Recurrent Malignant Male Reproductive System Neoplasm;   Recurrent Malignant Mesothelioma;   Recurrent Malignant Neoplasm of Multiple Primary Sites;   Recurrent Malignant Oral Neoplasm;   Recurrent Malignant Pharyngeal Neoplasm;   Recurrent Malignant Skin Neoplasm;   Recurrent Malignant Soft Tissue Neoplasm;   Recurrent Malignant Solid Neoplasm;   Recurrent Malignant Thyroid Gland Neoplasm;   Recurrent Malignant Urinary System Neoplasm;   Recurrent Melanoma of the Skin;   Refractory Cutaneous Melanoma;   Refractory Malignant Bone Neoplasm;   Refractory Malignant Endocrine Neoplasm;   Refractory Malignant Female Reproductive System Neoplasm;   Refractory Malignant Male Reproductive System Neoplasm;   Refractory Malignant Mesothelioma;   Refractory Malignant Neoplasm of Multiple Primary Sites;   Refractory Malignant Oral Neoplasm;   Refractory Malignant Pharyngeal Neoplasm;   Refractory Malignant Skin Neoplasm;   Refractory Malignant Soft Tissue Neoplasm;   Refractory Malignant Solid Neoplasm;   Refractory Malignant Thyroid Gland Neoplasm;   Refractory Malignant Urinary System Neoplasm
    Interventions:   Biological: Cord Blood-derived Expanded Allogeneic Natural Killer Cells;   Drug: Cyclophosphamide;   Drug: Etoposide
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Granulosa Cell Ovarian Cancer;   Low Grade Serous Ovarian/ Primary Peritoneal Cancer;   Endometrioid Endometrial Cancer
    Intervention:   Drug: Onapristone ER
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Context Therapeutics
    Recruiting

  • Conditions:   Bladder Carcinoma;   Breast Carcinoma;   Colorectal Carcinoma;   Lung Carcinoma;   Malignant Female Reproductive System Neoplasm;   Malignant Neoplasm
    Interventions:   Other: Communication Intervention;   Other: Educational Intervention;   Other: Internet-Based Intervention;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Other Cancer;   Gastrointestinal Cancer;   Thoracic Cancer;   Gynecologic Cancer
    Interventions:   Other: eSyM App Usage;   Other: SASS Questionnaire
    Sponsors:   Dana-Farber Cancer Institute;   National Cancer Institute (NCI);   RTI International;   Baptist Memorial Health Care Corporation;   Dartmouth-Hitchcock Medical Center;   Maine Medical Center;   West Virginia University;   Lifespan
    Not yet recruiting

  • Conditions:   Advanced Malignant Neoplasm;   Castleman Disease;   Digestive System Carcinoma;   Erdheim-Chester Disease;   Lip and Oral Cavity Carcinoma;   Lymphangioleiomyomatosis;   Malignant Endocrine Neoplasm;   Malignant Female Reproductive System Neoplasm;   Malignant Male Reproductive System Neoplasm;   Malignant Neoplasm;   Malignant Respiratory Tract Neoplasm;   Malignant Thoracic Neoplasm;   Malignant Urinary System Neoplasm;   Mesothelial Neoplasm;   Metastatic Malignant Neoplasm;   Metastatic Urothelial Carcinoma;   Neurofibromatosis Type 2;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Breast Carcinoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Digestive System Carcinoma;   Recurrent Female Reproductive System Carcinoma;   Recurrent Male Reproductive System Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Pharyngeal Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Refractory Malignant Neoplasm;   Soft Tissue Neoplasm;   Stage III Breast Cancer AJCC v7;   Stage III Pharyngeal Cancer;   Stage IIIA Breast Cancer AJCC v7;   Stage IIIB Breast Cancer AJCC v7;   Stage IIIC Breast Cancer AJCC v7;   Stage IV Breast Cancer AJCC v6 and v7;   Stage IV Pharyngeal Cancer;   Stage IVA Pharyngeal Cancer;   Stage IVB Pharyngeal Cancer;   Stage IVC Pharyngeal Cancer;   Thyroid Gland Neoplasm
    Interventions:   Biological: Bevacizumab;   Biological: Cetuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temsirolimus;   Drug: Valproic Acid
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Advanced Malignant Solid Neoplasm;   KRAS Gene Mutation;   Malignant Female Reproductive System Neoplasm;   Metastatic Malignant Solid Neoplasm;   NRAS Gene Mutation;   Recurrent Lung Carcinoma;   Recurrent Malignant Solid Neoplasm;   Recurrent Pancreatic Carcinoma;   Stage III Lung Cancer AJCC v7;   Stage III Pancreatic Cancer AJCC v6 and v7;   Stage IV Lung Cancer AJCC v7;   Stage IV Pancreatic Cancer AJCC v6 and v7;   Unresectable Malignant Solid Neoplasm
    Interventions:   Biological: Navitoclax;   Drug: Trametinib
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer;   Stage I Colorectal Cancer;   Stage II Colorectal Cancer;   Stage III Colorectal Cancer;   Gynecologic Cancer;   Stage I Gynecologic Cancer;   Stage II Gynecologic Cancer;   Stage III Gynecologic Cancer
    Interventions:   Other: Acupuncture;   Other: Sham Acupuncture;   Other: 8 week waiting period + optional Acupuncture
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Condition:   Gynecologic Tumor
    Interventions:   Device: MR Fingerprinting;   Device: QTI
    Sponsor:   Dana-Farber Cancer Institute
    Recruiting

  • Conditions:   Breast Cancer;   Ovarian Cancer;   Uterine Cancer
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   Cancer of the Cervix;   Vulvar Cancer;   Esophageal Cancer;   Anal Canal Cancer
    Intervention:   Other: FDG PET scan
    Sponsor:   Duke University
    Recruiting

  • Conditions:   Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulvar Cancer;   Bladder Cancer
    Intervention:   Device: Image-Guided Brachytherapy
    Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   National Cancer Institute (NCI);   Maryland Cigarette Restitution Fund
    Recruiting

  • Conditions:   TNBC - Triple-Negative Breast Cancer;   Ovarian Cancer
    Interventions:   Drug: AB928;   Drug: IPI-549;   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: nanoparticle albumin-bound paclitaxel (NP)
    Sponsors:   Arcus Biosciences, Inc.;   Infinity Pharmaceuticals, Inc.
    Recruiting